Acumen Pharmaceuticals
ABOS
ABOS
57 hedge funds and large institutions have $106M invested in Acumen Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 7 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
39% less capital invested
Capital invested by funds: $173M → $106M (-$66.9M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $78K
Holders
57
Holding in Top 10
1
Calls
–
Puts
$78K
Top Buyers
| 1 | +$3.63M | |
| 2 | +$2.82M | |
| 3 | +$2.66M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$2.6M |
| 5 |
PA
Perceptive Advisors
New York
|
+$2.33M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$4.24M | |
| 3 | -$4.07M | |
| 4 |
HF
HRT Financial
New York
|
-$553K |
| 5 |
E
Ergoteles
New York
|
-$522K |